Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis

References

• Van Wyck, D. B., Stivelman, J. C., Ruiz, J., Kirlin, L. F., Katz, M. A. and Ogden, D. A. (1989). Iron status in patients receiving erythropoietin for dialysis associated anaemia. Kidney Int., 35, 712–716.
   PubMed Web of Science ®Google Scholar
• Van Wyck, D. B., Martin, D. K. and Bonus, M. (1990). Value of transferrin saturation in assessing iron status in dialysis associated anaemia. J. Am. Soc. Nephrol., 1, 408 (abstr).
   Google Scholar
• Moreb, J., Popovitzer, M. M., Freidlander, M. M., Konijn, A. M. and Hershko, C. (1983). Evaluation of iron status in patients on chronic haemodialysis: relative usefulness of bone marrow heamosiderosis, serum ferritin, transferrin saturation, MCV and red cell protoporphyrin. Nephron., 35, 196–200.
   PubMedGoogle Scholar
• Brown, R. D., Benfatta, J., Gibson, J. and Kronenburg, H. (1988). Red cell ferritin and iron stores in patients with chronic disease Eur. J. Haematol., 40, 136.
   PubMed Web of Science ®Google Scholar
• MacDougall, I. C., Cavill, I., Hulme, B., Bain, B., McGregor, E., McKay, P., Sanders, E., Coles, G. A. and Williams, J. D. (1990). Detection of functional iron deficiency during erythropoietin therapy. A new Approach. J. Am Soc. Neprol., 1, 402. (abstr.).
   PubMedGoogle Scholar
• Eschbach, J. W. and Adamson, J. W. (1980). Recombinant human erythropoietin, implications for nephrology. Am. J. Kidney Dis., 11, 203–209.
   Google Scholar
• Stivelman, J. C. (1989). Resistance to recombinant human erythropoietin therapy. A real clinical entity. Semin. Nephrol., 9, 8–11.
   PubMed Web of Science ®Google Scholar
• Winearls, C. G. (1989). Erythropoietin (review). Nephrol Dial Transplant., 4, 323–326.
   PubMedGoogle Scholar
• MacDougall, I. C., Hutton, D., Cavill, I., Coles, G. A. and Williams, J. D. (1989). Poor response to treatment of renal anaemia with EPO corrected by iron given intravenously. BMJ., 299, 157–158.
   PubMedGoogle Scholar
• Bhandari, S., Owda, A. K., Kendall, R. G., Moran, N., Norfolk, D. R., Turney, J. H. and Brownjohn, A. M. (1997). Red cell ferritin as a measure of iron deficiency anaemia in haemodialysis patients. Renal failure., 19 (b), 771–780.
   PubMedGoogle Scholar
• Muirhead, N. and Hodsman, A. B. (1990). Occult infection and resistance of anaemia to recombinant human erythropoietin therapy in renal failure. Nephrol Dial Transplant., 5, 232–234.
   PubMed Web of Science ®Google Scholar
• Miller, C. B., Jones, R. J. and Piantadosi, S. (1990). Decreased erythropoietin response in patients with the anaemia of cancer. N. Eng. J. Med., 322, 1689–1692.
   PubMed Web of Science ®Google Scholar
• Schwartz, K. A., Dombrouski, J., Burwatowska, H., Ledin, M. and Mayor, G. (1987). Microcytic anaemia in dialysis patients: reversible marker of aluminium toxicity. Am. J. Kidney Dis., 9, 217–223.
   PubMed Web of Science ®Google Scholar
• Barbour, G. L. (1979). Effect of parathyroidectomy on anaemia in chronic renal failure. Arch. intern. Med., 139, 889–891.
   PubMedGoogle Scholar
• Washio, M., Iseki, K. and Oh, Y. (1990). Transient increase of serum erythropoietin after subtotal para-thyroidectomy in patients with chronic haemodialysis. Kidney Int., 37, 285 (abstr.).
   Google Scholar
• Bell, J. D., Kincaid, W. R., Morgan, R. G., Bunce, H., Alperin, J. B., Sarles, H. E. and Remmers, A. R. (1980). Serum ferritin assay and bone marrow iron stores in patients on maintenance haemodialysis. Kidney Int., 17, 237–241.
   PubMed Web of Science ®Google Scholar
• Anastassiades, E. G., Howarth, D., Howarth, J., Shanks, D., Waters, H. M., Hyde, K., Gaerung, C. G., Yin, JAL and Gokal, R. (1993). Monitoring of iron requirements in renal patients on EPO. Nephrol Dial Trans., 8, 846–853.
   PubMed Web of Science ®Google Scholar
• Bhandari, S., Norfolk, D. R., Brownjohn, A. M. and Turney, J. H. (1998). Effective utilisation of Erythropoietin with intravenous iron therapy. J. Pharmacy and Therapeutics, Submitted.
   Google Scholar
• Cazzola, M., Dezza, L., Berganushi, G., Barbosi, G., Bellotti, V., Cadera, D., Cieriello, M. M., Quaglini, S., Arosio, P. and Ascari, E. (1983). Biological and clinical significance of red cell ferritin. Blood, 62, 1078–1087.
   PubMed Web of Science ®Google Scholar
• Herberg, S., Podrabinck, N., Galan, P., Amenya, I. and Roudier, M. (1980). Influence of inflammation on laboratory indicators of iron deficiency in the elderly. Nutr. Res., 6, 1259–1266.
   Web of Science ®Google Scholar
• Brunati, C., Piperno, A., Ginastoni, C., Perrino, M. L., Civati, G., Teatini, U., Perego, A., Fiorelli, G. and Minetti, L. (1990). Erythrocyte ferritin in patients on chronic haemodialysis treatment. Nehron, 54, 219–223.
   PubMed Web of Science ®Google Scholar
• Caravaca, F., Vagace, J. M., Aparicio, A., Groiss, J., Pizaroo, J. L., Alonso, N., Garcia, M. L., Arrobas, M., Cubero, J., Esparrago, J. and Sanchez-Casado, E. (1992). Assessment of iron status by erythrocyte ferritin in uraemic patients with or without recombinant human erythropoeitin. Am. J. Kidney Dis., 20, 3, 249–254.
   PubMed Web of Science ®Google Scholar
• Lawson, D. H., Bodely, K., King, P. C. and Linton, A. L. (1971). Iron metabolism in patients with chronic renal failure on regular dialysis therapy. Clin. Sci., 41, 345.
   PubMed Web of Science ®Google Scholar
• Donnely, S. M., Posen, G. and Ali, M. A. M. (1991). Oral iron absorption in haemodialysis patients treated with EPO. Clin. Invest. Med., 24, 271–276.
   Google Scholar
• D'Onofrio, G., Chirillo, R., Zini, G., Caenaro, G., Ommasi, M. and Micciulli, G. (1995). Simultaneous Measurement of Reticulocyte and red blood cell Indicies in healthy subjects and patients with microcytic and macrocytic anaemia. Blood, 85, 818–823.
   PubMed Web of Science ®Google Scholar
• Brugnara, C., Hipp, M. J., Irving, P. J., Lathrop, H., Lee, P. A., Minchello, E. M. and Winkelman, J. (1994). Automated reticulocyte counting and measurement of reticulocyte cellular indices. Haematopathology, 102, 623–632.
   Google Scholar
• Diaz-Tejeure, R., Madwell, F., Diez, J., Esparza, N. and Errastip and Purroy, A. (1989). Red cell distribution width: a method that improves detection of iron deficiency in chronic haemodialysis patients: Nephron, 53, 379–380.
   PubMed Web of Science ®Google Scholar
• Morgan, D. L. and Peck, S. D. (1988). The use of red cell distribution width in the detection of iron deficiency in chronic haemodialysis patients. Am. J. Clin. Pathol., 89, 513–515.
   PubMed Web of Science ®Google Scholar
• Docci, D., Delveccio, C., Gollini, C., Turei, F., Baldrati, L. and Gilli, P. (1989). Red blood cell volume distribution width (RDW) in uraemic patients on chronic haemodialysis. J. Artif. Organs., 12, 3, 170–174.
   Web of Science ®Google Scholar
• Morgan, T. (1972). The effect of intravenous iron on the haematocrit of patients on maintenance haemodialysis. Med. J. Aust., 1, 852–854.
   PubMedGoogle Scholar
• Stewart, W. K., Fleming, L. W. and Shepherd, A. M. M. (1976). Haemoglobin and serum iron responses to periodic intravenous iron-dextran infusions during maintenance haemodialysis. Nephron, 17, 121–129.
   PubMed Web of Science ®Google Scholar
• MacDougall, I. C., Hutton, R. D., Cavill, I., Coles, G. A. and Williams, J. D (1990). Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. BMJ., 300, 155–159.
   Google Scholar